Results 41 to 50 of about 20,084,391 (297)
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
As Open Access continues to gain importance in science policy, understanding the proportion of Open Access publications relative to the total research output of research-performing organizations, individual countries, or even globally has become ...
Johannes Schneider, Heinz Pampel
doaj +1 more source
Open Access und Verwertungsgesellschaft Wort
Wissenschaftliches Publizieren ist mit urheberrechtlichen Fragen verbunden. Insbesondere das Open-Access-Publizieren stellt viele Rechtsfragen neu, zum Beispiel dessen Kompatibilität mit dem Abschluss eines Vertrags mit Verwertungsgesellschaften zum ...
Marc Lange, Robert Wiese, Georg Fischer
doaj +1 more source
The Government of Vietnam is making efforts to rearrange state-owned enterprises (SOEs); there are many studies on restructuring and equitization of SOEs to form state-capital enterprises (SCEs); However, there is little research on combining two ...
Ngo Chin, Nguyen Thuan
doaj +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
An open chat with…Simon Rayner
Simon Rayner joined the FEBS Open Bio Editorial Board in March 2022. Currently, he is Professor of Bioinformatics at Oslo University Hospital and the University of Oslo in Norway. He received a PhD in computational solid‐state physics from the University
Ioannis Tsagakis, Simon Rayner
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Building Bridges Across Archives. Open Jerusalem Workshop in Paris
Building Bridges Across Archives. Designing Open Jerusalem Web Platform The second annual workshop of the ERC project Open Jerusalem will be held at Limonade&Co (Paris) and the French Foreign Office Archives (La Courneuve) on 9-10 May 2017. The workshop
Open Jerusalem
core +1 more source
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
Serving the scientific community: FEBS Open Bio in 2024
FEBS Open Bio is committed to not only publishing sound science but also to supporting early‐career researchers and the scientific community as a whole. In this editorial, we look back at how the journal recognised and rewarded excellent research in 2023
Duncan E. Wright, Miguel A. De la Rosa
doaj +1 more source

